A dual-targeting chimeric receptor (DTCR) PD1-DAP10/NKG2D increases the expression of PD1 and NKG2D on the surface of NK92 cells by viral transfection, and has comparable anti-tumor properties in a mouse tumor-bearing model constructed with SGC-7901 activity (139). This evidence concerns the gene KLRK1 and neoplasm.